Recently, there has been a renewed interest in calreticulin due to a discovery of calreticulin gene variants associated with chronic blood tumours known as myeloproliferative neoplasm (MPN).94, 95, 96. This evidence concerns the gene CALR and myeloproliferative neoplasm.